Received Apr 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Lack of drug effect/shingles; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a male patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced shingles (Verbatim: Lack of drug effect/shingles). The outcome of the shingles was unknown. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date:19-MAR-2025 The reporter was a friend of the consumer. The consumer informed the reporter that he had one dose of Shingrix administered and then he got shingles (lack of effect). The reporter stated that the consumer only had one dose administered (missed dose). The reporter declined to provide any demographic information for himself or information regarding the consumer. No other information provided/obtained including patient initials, DOB, HCP information/consent, lot number, date vaccinated, date diagnosed with shingles, outcome, dose, or route of administration.